In Compliance with Regulation 74(5) of SEBI (Depository and Participant) Regulation 2018, Sandu Pharmaceuticals has forwarded a copy of certificate received by them from Link Intime India, the Registrar and Share Transfer Agents of the Company for the Quarter ended 31st March 2022.
The above information is a part of company’s filings submitted to BSE.